Benchmark lowered the firm’s price target on MaxLinear (MXL) to $20 from $28 and keeps a Buy rating on the shares. The firm lowered its price target to reflect sector-wide multiple compression, but despite macro headwinds views MaxLinear as undervalued given it is trading at about a40% discount to peers and the firm sees its growth outlook as intact, the analyst tells investors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MXL: